Analysis of LPS released from Salmonella abortus equi in human serum
- PMID: 1716342
- DOI: 10.1016/0882-4010(91)90070-q
Analysis of LPS released from Salmonella abortus equi in human serum
Abstract
We investigated in which form lipopolysaccharide (LPS) is released from live bacteria incubated with human serum and whether the released LPS can interact with high density lipoprotein (HDL), the main transport protein for purified LPS in circulation. Live biotinylated Salmonella abortus equi bacteria were incubated with fresh serum (37 degrees C; 2 h). The released LPS was isolated by immunoprecipitation or immunoabsorption using specific anti-O antibodies. It was analysed and compared with purified LPS, also incubated with serum under identical conditions. Immunoprecipitation led to a 35% recovery and immunoabsorption to quantitative recovery of released or purified LPS. Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and subsequent immunoblot analysis revealed that all molecular species present in the purified LPS were present in the released LPS. The rough fraction, which was co-isolated from serum together with the true smooth (O-polysaccharide-containing) molecules, exhibited S. minnesota rough mutant Rb antigenic specificity. In the immunoprecipitated material two forms of released LPS were identified. One represented LPS associated with a biotinylated bacterial component with an apparent molecular mass of 35-36 kDa, which was identified as OmpA, a major outer membrane protein. The OmpA-associated LPS was free of HDL. Another part of the released LPS was free of biotinylated bacterial components. This portion of LPS was associated with HDL, indicating that the interaction with HDL may also proceed with a part of LPS released from bacteria.
Similar articles
-
A quantitative analysis of C3 binding to O-antigen capsule, lipopolysaccharide, and outer membrane protein of E. coli 0111B4.J Immunol. 1984 Jan;132(1):369-75. J Immunol. 1984. PMID: 6197449
-
Immunoblot analysis of the R-form lipopolysaccharide from Salmonella S forms.Zentralbl Bakteriol. 1992 Oct;277(3):288-95. doi: 10.1016/s0934-8840(11)80905-9. Zentralbl Bakteriol. 1992. PMID: 1283089
-
C3 binds preferentially to long-chain lipopolysaccharide during alternative pathway activation by Salmonella montevideo.J Immunol. 1986 Jan;136(2):710-5. J Immunol. 1986. PMID: 2416822
-
Pseudomonas aeruginosa antigens as potential vaccines.FEMS Microbiol Rev. 1997 Nov;21(3):243-77. doi: 10.1111/j.1574-6976.1997.tb00353.x. FEMS Microbiol Rev. 1997. PMID: 9451816 Review.
-
Heterogeneity of Brucella abortus lipopolysaccharides.Res Microbiol. 1995 Sep;146(7):569-78. doi: 10.1016/0923-2508(96)80563-8. Res Microbiol. 1995. PMID: 8577998 Review.
Cited by
-
Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography, mass-spectrometry, ultracentrifugation, and electron microscopy.J Clin Invest. 1992 Mar;89(3):816-23. doi: 10.1172/JCI115660. J Clin Invest. 1992. PMID: 1541674 Free PMC article.
-
Enhancement of uptake of lipopolysaccharide in macrophages by the major outer membrane protein OmpA of gram-negative bacteria.Infect Immun. 1995 Jul;63(7):2697-705. doi: 10.1128/iai.63.7.2697-2705.1995. Infect Immun. 1995. PMID: 7790087 Free PMC article.
-
Bacterial endotoxins: biological properties and mechanisms of action.Mediators Inflamm. 1993;2(7):S11-6. doi: 10.1155/S0962935193000687. Mediators Inflamm. 1993. PMID: 18475562 Free PMC article.
-
Beneficial or deleterious effects of a preexisting hypersensitivity to bacterial components on the course and outcome of infection.Infect Immun. 2002 Oct;70(10):5596-603. doi: 10.1128/IAI.70.10.5596-5603.2002. Infect Immun. 2002. PMID: 12228287 Free PMC article.
-
Carnitine and congeners as regulators of tumour necrosis factor.Mediators Inflamm. 1993;2(7):S3. doi: 10.1155/S0962935193000663. Mediators Inflamm. 1993. PMID: 18475567 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical